Within-laboratory and between-laboratory variability in the measurement of anti-müllerian hormone determined within an external quality assurance scheme

Reproductive Biology

Volumn 13, Issue 3, 2013, Pages 255-257

  Zuvela, Emily ^a,b   Walls, Melanie ^b   Matson, Phillip ^c,d  

^a External Quality Assurance Schemes for Reproductive Medicine   (Australia)

^b Bethesda Hospital   (Australia)

^c Fertility North   (Australia)

^d EDITH COWAN UNIVERSITY   (Australia)

Author keywords

AMH; External quality assurance

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; AMH; ARTICLE; AUSTRALIA; BLOOD; DRUG STABILITY; EXTERNAL QUALITY ASSURANCE; FEMALE; HUMAN; LABORATORY; LABORATORY DIAGNOSIS; MIDDLE AGED; NEW ZEALAND; QUALITY CONTROL; REPRODUCIBILITY; STANDARD;

AMH; EXTERNAL QUALITY ASSURANCE;

ADULT; ANTI-MULLERIAN HORMONE; AUSTRALIA; DRUG STABILITY; FEMALE; HUMANS; LABORATORIES; MIDDLE AGED; NEW ZEALAND; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING;

EID: 84883530882     PISSN: 1642431X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repbio.2013.04.005     Document Type: Article

References (12)

1. Kelsey T.W., Wright P., Nelson S.M., Anderson R.A., Wallace W.H.B. A validated model of serum anti-Müllerian hormone from conception to menopause. PLoS ONE 2011, 6(7):e22024.
2. Nardo L.G., Gelbaya T.A., Wilkinson H., Roberts S.A., Yates A., Pemberton P., et al. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertility and Sterility 2009, 92(5):1586-1593.
3. Nelson S.M., Yates R.W., Lyall H., Jamieson M., Traynor I., Gaudoin M., et al. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Human Reproduction 2009, 24(4):867-875.
4. Streuli I., Fraisse T., Chapron C., Bijaoui G., Bischof P., de Ziegler D. Clinical uses of anti-Müllerian hormone assays: pitfalls and promises. Fertility and Sterility 2009, 91(1):226-230.
5. Wallace A.M., Faye S.A., Fleming R., Nelson S.M. A multicentre evaluation of the new Beckman Coulter anti-Müllerian hormone immunoassay (AMH Gen II). Annals of Clinical Biochemistry 2011, 48(4):370-373.
6. Kumar A., Kalra B., Patel A., McDavid L., Roudebush W.E. Development of a second generation anti-Müllerian hormone (AMH) ELISA. Journal of Immunological Methods 2010, 362(1/2):51-59.
7. Bland J., Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, i307-i310.
8. Nelson S.M., La Marca A. The journey from the old to the new AMH assay: how to avoid getting lost in the values. Reproductive Biomedicine Online 2011, 23(4):411-420.
9. Li H., Ng E., Wong B., Anderson R., Ho P., Yeung W. Correlation between three assay systems for anti-Müllerian hormone (AMH) determination. Journal of Assisted Reproduction and Genetics 2012, 1-4.
10. Fréour T., Mirallié S., Bach-Ngohou K., Denis M., Barrière P., Masson D. Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clinica Chimica Acta 2007, 375(1/2):162-164.
11. Rustamov O., Smith A., Roberts S.A., Yates A.P., Fitzgerald C., Krishnan M., et al. Anti-Müllerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Human Reproduction 2012, 27(10):3085-3091.
12. Fleming R., Fairbairn C., Blaney C., Lucas D., Gaudoin M. Stability of AMH measurement in blood and avoidance of proteolytic changes. Reproductive Biomedicine Online 2013, 26(2):130-132.